Tag: New Zealand

Fatigue in chronic fatigue syndrome: a discourse analysis of women’s experiential narratives

Abstract:

Chronic fatigue syndrome (CFS) is a debilitating condition. Approximately 75% of sufferers are women. The etiology of CFS is debated, but remains inconclusive. “Fatigue” is ill defined and conceptually problematic. The international multidisciplinary literature on CFS reveals a paucity of studies on women. Qualitative research to analyze women’s discourses on CFS is virtually absent.

Eleven New Zealand women of European descent with experience of CFS were interviewed in depth. Within the complex facets of CFS, this article reports specifically on an analysis of discourses on “fatigue.”

The predominant theme that emerged was that fatigue is articulated as “lack” or absence, which is not representable as an identifiable entity in biomedical terms. Parallels with chronic pain are briefly drawn. We conclude that approaches to CFS must respond to the diverse and complex constructions of the experience of fatigue evident in women’s narratives.

 

Source: Hart B, Grace VM. Fatigue in chronic fatigue syndrome: a discourse analysis of women’s experiential narratives. Health Care Women Int. 2000 Apr-May;21(3):187-201. http://www.ncbi.nlm.nih.gov/pubmed/11111465

 

Epidemic neuromyasthenia and chronic fatigue syndrome in west Otago, New Zealand. A 10-year follow-up

Abstract:

BACKGROUND: In 1984, an outbreak of an illness characterized by prolonged unexplained fatigue was reported in West Otago, New Zealand. This outbreak resembled other reported outbreaks of epidemic neuromyasthenia in that affected individuals presented with a spectrum of complaints ranging from transient diarrhea and upper respiratory disorders to chronic fatigue syndrome (CFS).

OBJECTIVE: To obtain a perspective on the natural history of CFS not possible in clinic-based studies.

METHODS: Twenty-three of the 28 patients in the original report were contacted and asked to complete written questionnaires. Interviews were obtained in person or via telephone.

RESULTS: Ten (48%) of the 21 patients with satisfactory interviews appeared to meet the current Centers for Disease Control and Prevention (CDC) case definition of CFS, and 11 were classified as having prolonged or idiopathic fatigue. A return to premorbid activity was seen in most (n = 16 patients, although some reported the need to modify their lifestyle to prevent relapses. A female predominance was noted in those meeting the CDC case definition for CFS, whereas males predominated in patients diagnosed as having prolonged or idiopathic fatigue.

CONCLUSIONS: The high proportion of patients recovering from CFS in the West Otago cluster suggests that epidemic-associated CFS has a better prognosis than sporadic cases. Female sex was confirmed as an important risk factor for CFS.

 

Source: Levine PH, Snow PG, Ranum BA, Paul C, Holmes MJ. Epidemic neuromyasthenia and chronic fatigue syndrome in west Otago, New Zealand. A 10-year follow-up. Arch Intern Med. 1997 Apr 14;157(7):750-4. http://www.ncbi.nlm.nih.gov/pubmed/9125006

 

Did Cook’s sailors have Tapanui ‘flu? –chronic fatigue syndrome on the Resolution

Abstract:

The 1982 publication of the Resolution journal of Johann George Reinhold Forster provided justification for his recognition as a scientist, and gave a remarkable insight into his character. It also included an account of an illness suffered by many of the sloop’s crew, including Forster, after a period ashore at Queen Charlotte Sound. The symptoms of the illness were remarkably similar to those now clustered as the chronic fatigue syndrome.

 

Source: St George IM. Did Cook’s sailors have Tapanui ‘flu? –chronic fatigue syndrome on the Resolution. N Z Med J. 1996 Jan 26;109(1014):15-7. http://www.ncbi.nlm.nih.gov/pubmed/8628527

 

General practitioners acceptance of the validity of chronic fatigue syndrome as a diagnosis

Abstract:

AIM: To identify whether general practitioners accept the validity of a diagnosis of chronic fatigue syndrome (CFS).

METHOD: An anonymous questionnaire was sent out to 98 general practitioners in Otago.

RESULTS: The clinical validity of chronic fatigue syndrome was accepted by 74 (90%); 57 believed they had sufficient knowledge about the condition to make a differential diagnosis; 72 indicated they had had patients with chronic fatigue syndrome in the past; 62 currently had patients; there is a minimum prevalence rate of 167/100,000 in the general practice population; 83 replies were received.

CONCLUSION: The 90% acceptance rate of chronic fatigue syndrome as a clinically valid diagnosis suggests that amongst the Otago general practitioners the controversy had receded. The low numbers suggest that they are on the conservative end of the diagnostic spectrum.

 

Source: Denz-Penhey H, Murdoch JC. General practitioners acceptance of the validity of chronic fatigue syndrome as a diagnosis. N Z Med J. 1993 Apr 14;106(953):122-4. http://www.ncbi.nlm.nih.gov/pubmed/8474729

 

Myalgic encephalomyelitis

Comment on: Myalgic encephalomyelitis. [J R Soc Med. 1991]

 

The exchange of views between Drs Wessely and Wilson in the correspondence columns of the March issue of the Journal (March 1991 JRSM, p 182) highlights the divergence of opinion concerning the nature of myalgic encephalomyelitis (ME).

Recognition of ME as a significant health problem in New Zealand dates from an outbreak of ‘Tapanui ‘flu’ in a small country town in 1983. As it seemed possible that the wide range of symptoms could be indicative of impaired capillary blood flow, we studied the filtrability of blood samples from members of ME support groups. We found that subjects who were acutely unwell had prolonged blood filtration times which returned towards normal in the chronic state.

More recently it has been shown that ME symptoms are associated with increased percentages of nondiscocytic erythrocytes and the percentage of such cells showed an inverse correlation with wellbeing. The significance of altered red cell shape in the pathogenesis of ME has been discussed and it has been found that an injection of vitamin B12 improved wellbeing within 24 h. The loss of symptoms was associated with reduced percentages of nondiscocytes in about 50% of subjects. Those who failed to perceive a beneficial response from the B12 showed no change in red cell shape. Further studies at varying degrees of completion confirm and extend the published observations.

You can read the rest of this comment here: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1295578/pdf/jrsocmed00119-0075a.pdf

 

Source: Simpson LO. Myalgic encephalomyelitis. J R Soc Med. 1991 Oct;84(10):633. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1295578/